Hepatitis C Virus
Pharmasset Announces Second Fiscal Quarter 2007 Financial Results
Published in Hepatitis Weekly, June 25th, 2007
Pharmasset, Inc. (NASDAQ:VRUS), a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections, announced the unaudited financial results for the second fiscal quarter ended March 31, 2007. For the three months ended March 31, 2007, Pharmasset reported a net loss attributable to common shareholders of $1.7 million, or $0.16 per share, as compared to a net loss attributable to common shareholders of $0.9 million, or $0.09 per share for the same period in 2006.
Revenues were $5.5 million during the second fiscal quarter ended March 31, 2007, of which $5.0 million was from our hepatitis C virus (HCV)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2007-06-25)
More Articles from Hepatitis Weekly
- Hepatitis C Virus
FierceBiotech Names Intarcia Therapeutics as One of the "Fierce 15" Biotech Companies of 2007 - Hepatitis C Virus
Valopicitabine Combined with Standard of Care Cleared Hepatitis C Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a Phase II Trial - Hepatitis C Virus
ViroPharma Announces Completion of Enrollment in 500mg BID Arms of HCV-796 Phase 2 Study - HIV/AIDS
Pharmasset Presents Clevudine and Racivir Data at the International HIV Drug Resistance Workshop - Chemistry
Study results from Uppsala University, Department of Medicinal Chemistry update understanding of chemistry - Hepatitis A Virus Epidemiology
National Public Health Institute publishes research in hepatitis A virus epidemiology - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
